Hepatitis C Virus-infected, HCV-RNA-negative Patients with Bleeding Disorders - Relationship to Age, HIV and Treatment

References

• van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo Q-L, Kuo G, Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; 2: 297–9.
   PubMed Web of Science ®Google Scholar
• Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, Vargas V, Genescá J, Buti M, Guardia J, Houghton M, Choo Q-L, Kuo G. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–7.
   Google Scholar
• Roggendorf M, Deinhardt F, Rasshofer R, Eberle J, Hopf U, Möller B, Zachoval R, Pape G, Schramm W, Rommel F. Antibodies to hepatitis C virus. Lancet 1989; 2: 324–5.
   Google Scholar
• Noel L, Guerois C, Maisonneuve P, Verroust F, Laurian Y. Antibodies to hepatitis C virus in haemophilia. Lancet 1989; 2: 560.
   Google Scholar
• Ludlam CA, Chapman D, Cohen B, Litton PA. Antibodies to hepatitis C virus in haemophilia. Lancet 1989; 2: 560–1.
   PubMedGoogle Scholar
• Schulman S, Grillner L. Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners. Scand J Infect Dis 1990; 22: 393–7.
   PubMed Web of Science ®Google Scholar
• Widell A, Hansson BG, Berntorp E, Moestrup T, Johansson HP, Hansson H, Nordenfelt E. Antibody to a hepatitis C virus related protein among patients at high risk for hepatitis B. Scand J Infect Dis 1991; 23: 19–24.
   Google Scholar
• Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD, Bianchi L, Desmet V, Scheuer P, Popper H. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66: 367–72.
   PubMed Web of Science ®Google Scholar
• Polesky HF, Hanson MR. Transfusion associated hepatitis C virus (non-A, non-B) infection. Arch Pathol Lab Med 1989; 113: 232–5.
   PubMedGoogle Scholar
• Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M. Detection of hepatitis C viral sequenes in non-A, non-B hepatitis. Lancet 1990; 335: 1–3.
   Google Scholar
• Kato N, Yokosuka O, Omata M, Hosoda K, Ohto M. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 1990; 86: 1764–7.
   Google Scholar
• Widell A, Ma˚nsson AS, Sundström G, Hansson BG, Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol 1991; 35: 253–8.
   PubMed Web of Science ®Google Scholar
• Schulman S, Lindgren A-Ch, Petrini P, Allander T. Transmission of hepatitis C with pasteurised factor VIII. Lancet 1992; 340: 305–6.
   Google Scholar
• Dore GJ, Kaldor JM, McCaughan GW. Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. Br Med J 1997; 315: 333–7.
   Google Scholar
• Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 1996; 41: 1265–72.
   Google Scholar
• Chambost H, Gerolami V, Halfon P, Thuret I, Michel G, Sicardi F, Rousseau S, Perrimond H, Cartouzou G. Persistent hepatitis C virus RNA replication in haemophiliacs: role of co-infection with human immunodeficiency virus. Br J Haematol 1995; 91: 703–7.
   Google Scholar
• Takayama S, Taki M, Meguro T, Nishikawa K, Shiraki K, Yamada K. Virological characteristics of HCV infection in Japanese haemophiliacs. Haemophilia 1997; 3: 131–6.
   PubMedGoogle Scholar
• Picchio GR, Nakatsuno M, Boggiano C, Sabbe R, Corti M, Daruich J, Perez-Bianco R, Tezanos-Pinto M, Kokka R, Wilber J, Mosier D. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. J Med Virol 1997; 52: 219–25.
   Google Scholar
• Cribier B, Schmitt C, Rey D, Uhl G, Lang JM, Vetter D, Kirn A, Stoll-Keller F. HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype. Res Virol 1997; 148: 267–71.
   Google Scholar
• Tovo PA, Palomba E, Ferraris G, Principi N, Ruga E, Dallacasa P, Maccabruni A. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis 1997; 25: 1121–4.
   Google Scholar
• Sabin CA, Telfer P, Phillips AN, Bhagani S, Lee CA. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997; 175: 164–8.
   Google Scholar
• Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657–61.
   PubMed Web of Science ®Google Scholar
• Schopnick RI, Brettler DB, Forand P, McDonald M. DDI and liver tests in HIV-1 seropositive haemophiliacs. Haemophilia 1997; 3: 35–8.
   PubMedGoogle Scholar
• Lee CA, Phillips AN, Elford J, Janossy G, Griffiths P, Kernoff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. Br Med J 1991; 303: 1093–6.
   PubMedGoogle Scholar
• Diamondstone LS, Blakley SA, Rice JC, Clark RA, Goedert JJ. Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. Am J Epidemiol 1995; 142: 304–13.
   Google Scholar
• Fried MW, Hoofnagle JH. Therapy of hepatitis C. Semin Liver Dis 1995; 15: 82–91
   PubMedGoogle Scholar